CardioDiagnostics
Private Company
Total funding raised: $63.1M
Overview
CardioDiagnostics (CardioOne Connect) is a private, commercial-stage company offering a proprietary platform for ambulatory cardiac diagnostics, remote patient monitoring (RPM), and chronic care management (CCM). Founded in 2015 and headquartered in Chicago, the company targets cardiology practices with a service-based model designed to improve patient outcomes, boost practice revenue, and reduce operational burden. Its integrated technology and care team support aim to transform traditional episodic cardiac care into a continuous, data-driven management model.
Technology Platform
A proprietary, integrated cloud-based platform for remote patient monitoring, chronic care management, and ambulatory cardiac diagnostics. It transforms remote patient data into actionable insights, coordinates care teams, and aligns providers, patients, and caregivers.
Funding History
90Opportunities
Risk Factors
Competitive Landscape
The competitive landscape is crowded and includes large medical device companies (e.g., Medtronic, Boston Scientific) with monitoring devices, pure-play RPM software vendors (e.g., Biofourmis, Vivify Health), and major EHR providers (e.g., Epic, Cerner) adding care management modules. CardioDiagnostics differentiates through its cardiology-specific focus, integrated platform combining all three service lines, and its turnkey model with outsourced personnel.